Amino Collective

Venture Capital
32investments
1exit
$123.5Mraised by its portfolio in 12 months
153open roles in its portfolio

Overview

Amino Collective’s primary investment focus lies within the realms of health and bio. We help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists.

Investor profile

Venture capital
Investments
32
22 of them startups
Hiring now
14
153 open roles
Rounds in 12 months
5
$123.5M raised
Exits
1
Focusshare of its companies
Health Care 58%Biotechnology 47%Artificial Intelligence 32%Financial Services 5%Science & Engineering 5%Software 5%
Where its companies are
United Kingdom 28%United States 19%Switzerland 6%Netherlands 3%Germany 3%Spain 3%Sweden 3%
Stage of its companies
Pre-seed & seed 43%Series A 29%Series B 21%Series C and later 7%
Its companies, the freshest money firstAll 32 investments
Frontier ComputingPre-Seed $10M · 1 mo ago Tandem HealthSeries B $100M · 1 mo ago · 61 roles Lindus HealthVenture round · 2 mo ago · 4 roles Sensible BiotechnologiesVenture round $13.5M · 2 mo ago CoSyne Therapeutics LimitedVenture round · 3 mo ago Vira HealthVenture round · 15 mo ago · 16 roles Inductive BioSeries A $25M · 17 mo ago · 4 roles REMATIQSeed $5.8M · 18 mo ago · 10 roles JunctionVenture round $18M · 19 mo ago · 13 roles CradleSeries B $73M · 22 mo ago · 8 roles Enveda BiosciencesVenture round $130M · 23 mo ago · 9 roles ExpressionEditsSeed $13M · 2 yr ago
153 open roles at 14 of its companies
Hiring fastestroles opened in 30 days
Tandem Health24 new roles in 30 days Junction6 new roles in 30 days Recursion Pharmaceuticals3 new roles in 30 days Seqera3 new roles in 30 days
Co-investorscompanies they hold together
Y Combinator 6 shared Hummingbird Ventures 4 shared Backed VC 4 shared BlueYard Capital 3 shared Phoenix Court 3 shared Airstreet 3 shared Speedinvest 3 shared Kaya VC 2 shared Obvious Ventures 2 shared Lux Capital 2 shared
Similar investorstheir companies share markets and countries
SR One Flagship Pioneering ARCH Venture Partners Illumina Ventures OrbiMed Kindred Capital Cambridge Angels Epidarex Capital
Sources: its portfolio page, read Nov 3

People

Manuel Grossmann
Managing Director
company's site
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data